To improve the efficiency of the diagnostic process by using standardized, validated instruments to screen for potentially co-morbid disorders in new patients, and also to monitor treatment response at pre-determined intervals (individualized to the patient) using standardized, validated symptom measures to track progress and readily identify emerging concerns.